Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Eclampsia | 4 | 2020 | 212 | 1.730 |
Why?
|
| Placenta | 4 | 2020 | 516 | 1.540 |
Why?
|
| CD55 Antigens | 4 | 2014 | 17 | 1.500 |
Why?
|
| Complement Activation | 3 | 2020 | 94 | 1.050 |
Why?
|
| Complement C5a | 2 | 2015 | 36 | 1.040 |
Why?
|
| Complement C3 | 2 | 2020 | 78 | 0.830 |
Why?
|
| Receptors, Complement 3b | 1 | 2020 | 20 | 0.760 |
Why?
|
| Complement System Proteins | 1 | 2020 | 139 | 0.690 |
Why?
|
| Fetal Development | 1 | 2020 | 120 | 0.680 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2018 | 10 | 0.670 |
Why?
|
| Nitric Oxide | 2 | 2013 | 644 | 0.660 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2018 | 125 | 0.620 |
Why?
|
| Trophoblasts | 1 | 2018 | 138 | 0.610 |
Why?
|
| Complement C4a | 1 | 2015 | 6 | 0.550 |
Why?
|
| Complement Factor B | 1 | 2015 | 13 | 0.540 |
Why?
|
| Amniotic Fluid | 1 | 2015 | 123 | 0.510 |
Why?
|
| Complement Inactivator Proteins | 1 | 2014 | 5 | 0.510 |
Why?
|
| Uropathogenic Escherichia coli | 1 | 2014 | 24 | 0.470 |
Why?
|
| Bacterial Adhesion | 1 | 2014 | 147 | 0.450 |
Why?
|
| Abortion, Spontaneous | 1 | 2014 | 112 | 0.450 |
Why?
|
| ELAV Proteins | 1 | 2013 | 18 | 0.450 |
Why?
|
| Caveolae | 1 | 2012 | 20 | 0.440 |
Why?
|
| Sp1 Transcription Factor | 1 | 2013 | 188 | 0.410 |
Why?
|
| Gene Expression | 1 | 2020 | 3570 | 0.400 |
Why?
|
| Pregnancy | 6 | 2020 | 7573 | 0.330 |
Why?
|
| Endometrium | 1 | 2012 | 470 | 0.330 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 4549 | 0.320 |
Why?
|
| Membrane Cofactor Protein | 2 | 2020 | 10 | 0.310 |
Why?
|
| Epithelial Cells | 1 | 2014 | 1818 | 0.290 |
Why?
|
| Complement Inactivating Agents | 1 | 2020 | 16 | 0.190 |
Why?
|
| Receptors, Complement | 1 | 2020 | 48 | 0.190 |
Why?
|
| Complement Pathway, Alternative | 1 | 2020 | 20 | 0.180 |
Why?
|
| Down-Regulation | 2 | 2014 | 2074 | 0.160 |
Why?
|
| Adrenomedullin | 1 | 2019 | 104 | 0.160 |
Why?
|
| Cell Line | 3 | 2019 | 5114 | 0.160 |
Why?
|
| Insulin-Secreting Cells | 1 | 2019 | 154 | 0.150 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 104 | 0.150 |
Why?
|
| Gene Frequency | 1 | 2020 | 1163 | 0.150 |
Why?
|
| Signal Transduction | 1 | 2014 | 11965 | 0.130 |
Why?
|
| Adhesins, Escherichia coli | 1 | 2014 | 24 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2020 | 1467 | 0.120 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2014 | 41 | 0.120 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 2216 | 0.120 |
Why?
|
| Female | 8 | 2020 | 141928 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 1498 | 0.120 |
Why?
|
| RNA, Messenger | 2 | 2014 | 6150 | 0.120 |
Why?
|
| Nitroso Compounds | 1 | 2013 | 17 | 0.110 |
Why?
|
| Nitric Oxide Donors | 1 | 2013 | 51 | 0.110 |
Why?
|
| Fimbriae Proteins | 1 | 2013 | 34 | 0.110 |
Why?
|
| Insulin | 1 | 2019 | 1454 | 0.110 |
Why?
|
| Cyclic GMP | 1 | 2012 | 116 | 0.110 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2013 | 220 | 0.110 |
Why?
|
| Endosomes | 1 | 2012 | 109 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2018 | 2450 | 0.100 |
Why?
|
| Cysteine | 1 | 2013 | 214 | 0.100 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 343 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 591 | 0.100 |
Why?
|
| Caveolin 1 | 1 | 2012 | 204 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1077 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2018 | 5637 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 6942 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 4053 | 0.080 |
Why?
|
| Binding Sites | 1 | 2013 | 2171 | 0.080 |
Why?
|
| Humans | 8 | 2020 | 261506 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2013 | 3536 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2054 | 0.070 |
Why?
|
| Escherichia coli | 1 | 2013 | 1203 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 1879 | 0.070 |
Why?
|
| Protein Binding | 1 | 2013 | 3438 | 0.070 |
Why?
|
| Case-Control Studies | 1 | 2015 | 6100 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 3101 | 0.070 |
Why?
|
| Adult | 3 | 2020 | 77950 | 0.060 |
Why?
|
| Young Adult | 1 | 2020 | 21445 | 0.050 |
Why?
|
| Receptors, Adrenomedullin | 1 | 2019 | 25 | 0.040 |
Why?
|
| Mice | 1 | 2020 | 34495 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 213 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 14551 | 0.040 |
Why?
|
| Animals | 1 | 2020 | 59536 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2019 | 1244 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 1143 | 0.030 |
Why?
|
| Mutation | 1 | 2013 | 15179 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2019 | 1555 | 0.030 |
Why?
|
| Middle Aged | 1 | 2015 | 86204 | 0.020 |
Why?
|